PHARMACOLOGY EVOLVE HESI EXAM (ACTUAL
EXAM 2025) | ALL QUESTIONS AND CORRECT
ANSWERS | VERIFIED ANSWERS | LATEST VERSION
| GRADED A+
A client who is HIV-positive is receiving combination therapy with the
antiviral medication zidovudine. Which instruction should the nurse include
in this client's teaching plan?
A. Take the drug as prescribed to cure HIV infections.
B. Use the drug to reduce the risk of transmitting HIV to sexual contacts.
C. Return to the clinic every 2 weeks for blood counts.
D. Report to the health care provider immediately if dizziness is
experienced. ---------CORRECT ANSWER-----------------C. Return to the
clinic every 2 weeks for blood counts.
Bone marrow depression with granulocytopenia is a severe but
common adverse effect of zidovudine. Careful monitoring of CBCs is
indicated. Options A and B are not correct instructions related to use
of this medication. Option D is an expected side effect. The client
should be instructed to avoid driving until this reaction improves.
A client with chronic gouty arthritis is talking allopurinol, 100 mg PO daily.
Which laboratory serum level should the nurse report to the health care
provider to determine the therapeutic outcome?
A. Prothrombin time
B. Uric acid level
C. White blood cell count
D. Creatinine level ---------CORRECT ANSWER-----------------B. Uric acid
level
The primary therapeutic outcome associated with allopurinol therapy
is reduced serum uric acid levels with a lower frequency of acute
gouty attacks, so option B should be reported to the health care
,provider. Options A, C, and D are not related to the effectiveness of
allopurinol.
A client who is receiving chlorpromazine HCl to control his psychotic
behavior also has a prescription for benztropine. When teaching the client
and/or significant others about these medications, what should the nurse
explain about the use of benztropine in the treatment plan for this client?
A. This medication will reduce the side effect of urinary retention.
B. This drug potentiates the effect of chlorpromazine HCl.
C. The benztropine is used to control extrapyramidal symptoms.
D. The combined effect of these drugs will modify psychotic behavior. -------
--CORRECT ANSWER-----------------C. The benztropine is used to control
extrapyramidal symptoms.
Benztropine, an anticholinergic drug, is used to control
extrapyramidal symptoms associated with chlorpromazine HCl
(Thorazine) use. Options A, B, and D are not accurate statements
regarding the use of benztropine for clients who are treated with
chlorpromazine HCl for the control of psychosis.
A client being treated for an acute myocardial infarction is to receive the
tissue plasminogen activator alteplase. The nurse would be correct in
providing which explanation to the client regarding the purpose of this
drug?
A. This drug is a nitrate that promotes vasodilation of the coronary arteries.
B. This drug is a clot buster that dissolves clots within a coronary artery.
C. This drug is a blood thinner that will help prevent the formation of a new
clot.
D. This drug is a volume expander that improves myocardial perfusion by
increasing output. ---------CORRECT ANSWER-----------------B. This drug is
a clot buster that dissolves clots within a coronary artery.
,t-PA, or tissue plasminogen activator, is a coronary-specific
fibrinolytic agent that dissolves clots within the coronary arteries.
This drug is not a calcium channel blocker or nitrate, which would
promote vasodilation of the coronary arteries. This medication is not
an anticoagulant, such as warfarin or heparin, which would prevent
new clot formation. Volume expansion is not provided by an infusion
of t-PA and would not necessarily improve myocardial perfusion
caused by an increased cardiac output in a client with coronary artery
disease.
The nurse has completed diabetic teaching for a client who has been newly
diagnosed with diabetes mellitus. Which statement by this client would
indicate to the nurse that further teaching is needed?
A. "Regular insulin can be stored at room temperature for 30 days."
B. "My legs, arms, and abdomen are all good sites to inject my insulin."
C. "I will always carry hard candies to treat hypoglycemic reactions."
D. "When I exercise, I should plan to increase my insulin dosage." ---------
CORRECT ANSWER-----------------D. "When I exercise, I should plan to
increase my insulin dosage."
Exercise helps facilitate the entry of glucose into the cell, so
increasing insulin doses with exercise would place the client at high
risk for a hypoglycemic reaction. Options A, B, and C reflect accurate
statements about the use of insulin and management of
hypoglycemic reactions.
A lidocaine IV infusion at 4 mg/min via infusion pump is prescribed for a
client having premature ventricular contractions (PVCs). The available
premixed infusion contains 2 mg/mL of D5W. How many milliliters per hour
should the nurse program the pump to deliver to this client?
A. 20
B. 24
C. 60
D. 120 ---------CORRECT ANSWER-----------------D. 120
, Option D is the correct calculation; 120 mL/hr = 1 mL/2 mg × 4 mg/min
× 60 min/hr.
A child is being treated with mebendazole for pinworms. Which type of diet
should the mother be instructed to feed the child while the child is receiving
this medication?
A. Lactose-free foods
B. High-fat diet
C. Vitamin C-enriched foods
D. High-fiber diet ---------CORRECT ANSWER-----------------B. High-fat diet
A high-fat diet increases the absorption of mebendazole, which
boosts the effectiveness of the medication in eliminating the
pinworms. Options A, C, and D are not related to the administration of
this medication.
During therapy with isoniazid, it is most important for the nurse to monitor
which laboratory value closely?
A. Liver enzyme levels
B. Blood urea nitrogen (BUN) level
C. Serum electrolyte levels
D. Complete blood count (CBC) ---------CORRECT ANSWER-----------------
A. Liver enzyme levels
The client receiving isoniazid is at risk for the development of
hepatitis; therefore, liver function test results should be monitored
carefully during drug therapy. Options B, C, and D are not specific
indicators of liver function, so they are not monitored closely during
isoniazid therapy.
EXAM 2025) | ALL QUESTIONS AND CORRECT
ANSWERS | VERIFIED ANSWERS | LATEST VERSION
| GRADED A+
A client who is HIV-positive is receiving combination therapy with the
antiviral medication zidovudine. Which instruction should the nurse include
in this client's teaching plan?
A. Take the drug as prescribed to cure HIV infections.
B. Use the drug to reduce the risk of transmitting HIV to sexual contacts.
C. Return to the clinic every 2 weeks for blood counts.
D. Report to the health care provider immediately if dizziness is
experienced. ---------CORRECT ANSWER-----------------C. Return to the
clinic every 2 weeks for blood counts.
Bone marrow depression with granulocytopenia is a severe but
common adverse effect of zidovudine. Careful monitoring of CBCs is
indicated. Options A and B are not correct instructions related to use
of this medication. Option D is an expected side effect. The client
should be instructed to avoid driving until this reaction improves.
A client with chronic gouty arthritis is talking allopurinol, 100 mg PO daily.
Which laboratory serum level should the nurse report to the health care
provider to determine the therapeutic outcome?
A. Prothrombin time
B. Uric acid level
C. White blood cell count
D. Creatinine level ---------CORRECT ANSWER-----------------B. Uric acid
level
The primary therapeutic outcome associated with allopurinol therapy
is reduced serum uric acid levels with a lower frequency of acute
gouty attacks, so option B should be reported to the health care
,provider. Options A, C, and D are not related to the effectiveness of
allopurinol.
A client who is receiving chlorpromazine HCl to control his psychotic
behavior also has a prescription for benztropine. When teaching the client
and/or significant others about these medications, what should the nurse
explain about the use of benztropine in the treatment plan for this client?
A. This medication will reduce the side effect of urinary retention.
B. This drug potentiates the effect of chlorpromazine HCl.
C. The benztropine is used to control extrapyramidal symptoms.
D. The combined effect of these drugs will modify psychotic behavior. -------
--CORRECT ANSWER-----------------C. The benztropine is used to control
extrapyramidal symptoms.
Benztropine, an anticholinergic drug, is used to control
extrapyramidal symptoms associated with chlorpromazine HCl
(Thorazine) use. Options A, B, and D are not accurate statements
regarding the use of benztropine for clients who are treated with
chlorpromazine HCl for the control of psychosis.
A client being treated for an acute myocardial infarction is to receive the
tissue plasminogen activator alteplase. The nurse would be correct in
providing which explanation to the client regarding the purpose of this
drug?
A. This drug is a nitrate that promotes vasodilation of the coronary arteries.
B. This drug is a clot buster that dissolves clots within a coronary artery.
C. This drug is a blood thinner that will help prevent the formation of a new
clot.
D. This drug is a volume expander that improves myocardial perfusion by
increasing output. ---------CORRECT ANSWER-----------------B. This drug is
a clot buster that dissolves clots within a coronary artery.
,t-PA, or tissue plasminogen activator, is a coronary-specific
fibrinolytic agent that dissolves clots within the coronary arteries.
This drug is not a calcium channel blocker or nitrate, which would
promote vasodilation of the coronary arteries. This medication is not
an anticoagulant, such as warfarin or heparin, which would prevent
new clot formation. Volume expansion is not provided by an infusion
of t-PA and would not necessarily improve myocardial perfusion
caused by an increased cardiac output in a client with coronary artery
disease.
The nurse has completed diabetic teaching for a client who has been newly
diagnosed with diabetes mellitus. Which statement by this client would
indicate to the nurse that further teaching is needed?
A. "Regular insulin can be stored at room temperature for 30 days."
B. "My legs, arms, and abdomen are all good sites to inject my insulin."
C. "I will always carry hard candies to treat hypoglycemic reactions."
D. "When I exercise, I should plan to increase my insulin dosage." ---------
CORRECT ANSWER-----------------D. "When I exercise, I should plan to
increase my insulin dosage."
Exercise helps facilitate the entry of glucose into the cell, so
increasing insulin doses with exercise would place the client at high
risk for a hypoglycemic reaction. Options A, B, and C reflect accurate
statements about the use of insulin and management of
hypoglycemic reactions.
A lidocaine IV infusion at 4 mg/min via infusion pump is prescribed for a
client having premature ventricular contractions (PVCs). The available
premixed infusion contains 2 mg/mL of D5W. How many milliliters per hour
should the nurse program the pump to deliver to this client?
A. 20
B. 24
C. 60
D. 120 ---------CORRECT ANSWER-----------------D. 120
, Option D is the correct calculation; 120 mL/hr = 1 mL/2 mg × 4 mg/min
× 60 min/hr.
A child is being treated with mebendazole for pinworms. Which type of diet
should the mother be instructed to feed the child while the child is receiving
this medication?
A. Lactose-free foods
B. High-fat diet
C. Vitamin C-enriched foods
D. High-fiber diet ---------CORRECT ANSWER-----------------B. High-fat diet
A high-fat diet increases the absorption of mebendazole, which
boosts the effectiveness of the medication in eliminating the
pinworms. Options A, C, and D are not related to the administration of
this medication.
During therapy with isoniazid, it is most important for the nurse to monitor
which laboratory value closely?
A. Liver enzyme levels
B. Blood urea nitrogen (BUN) level
C. Serum electrolyte levels
D. Complete blood count (CBC) ---------CORRECT ANSWER-----------------
A. Liver enzyme levels
The client receiving isoniazid is at risk for the development of
hepatitis; therefore, liver function test results should be monitored
carefully during drug therapy. Options B, C, and D are not specific
indicators of liver function, so they are not monitored closely during
isoniazid therapy.
